The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Suppression of Human Immunodeficiency Virus Type 1 Viral Load With Selenium Supplementation: A Randomized Controlled Trial
Abstract
BACKGROUND: Despite findings that selenium supplementation may improve immune functioning, definitive evidence of its impact on human immunodeficiency virus (HIV) disease severity is lacking. METHODS: High selenium yeast supplementation (200 mug/d) was evaluated in a double-blind, randomized, placebo-controlled trial. Intention-to-treat analyses assessed the effect on HIV-1 viral load and CD4 count after 9 months of treatment. Unless otherwise indicated, values are presented as mean +/- SD. RESULTS: Of the 450 HIV-1-seropositive men and women who underwent screening, 262 initiated treatment and 174 completed the 9-month follow-up assessment. Mean adherence to study treatment was good (73.0% +/- 24.7%) with no related adverse events. The intention-to-treat analyses indicated that the mean change (Delta) in serum selenium concentration increased significantly in the selenium-treated group and not the placebo-treated group (Delta = 32.2 +/- 24.5 vs 0.5 +/- 8.8 microg/L; P<.001), and greater levels predicted decreased HIV-1 viral load (P<.02), which predicted increased CD4 count (P<.04). Findings remained significant after covarying age, sex, ethnicity, income, education, current and past cocaine and other drug use, HIV symptom classification, antiretroviral medication regimen and adherence, time since HIV diagnosis, and hepatitis C virus coinfection. Follow-up analyses evaluating treatment effectiveness indicated that the nonresponding selenium-treated subjects whose serum selenium change was less than or equal to 26.1 microg/L displayed poor treatment adherence (56.8% +/- 29.8%), HIV-1 viral load elevation (Delta = +0.29 +/- 1.1 log(10) units), and decreased CD4 count (Delta = -25.8 +/- 147.4 cells/microL). In contrast, selenium-treated subjects whose serum selenium increase was greater than 26.1 microg/L evidenced excellent treatment adherence (86.2% +/- 13.0%), no change in HIV-1 viral load (Delta = -0.04 +/- 0.7 log(10) units), and an increase in CD4 count (Delta = +27.9 +/- 150.2 cells/microL). CONCLUSIONS: Daily selenium supplementation can suppress the progression of HIV-1 viral burden and provide indirect improvement of CD4 count. The results support the use of selenium as a simple, inexpensive, and safe adjunct therapy in HIV spectrum disease. Trial Registration isrctn.org Identifier: ISRCTN22553118.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., Wu, A. W., & PATIENT CARE COMMITTEE & ADHERENCE (2000) · AIDS Care · doi:10.1080/09540120050042891 · Cited by 1,428
A Randomized Trial of Multivitamin Supplements and HIV Disease Progression and Mortality
Fawzi, W. W., Msamanga, G. I., Spiegelman, D., Wei, R., Kapiga, S., Villamor, E., Mwakagile, D., Mugusi, F., Hertzmark, E., Essex, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040541 · Cited by 446
Cited by
Rayman, M. P. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61452-9 · Cited by 3,563
A Review of Micronutrients and the Immune System–Working in Harmony to Reduce the Risk of Infection
Gombart, A. F., Pierre, A., & Maggini, S. (2020) · Nutrients · doi:10.3390/nu12010236 · Cited by 1,358
Food-chain selenium and human health: emphasis on intake
Rayman, M. P. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508939830 · Cited by 798
The influence of selenium on immune responses
Hoffmann, P. R., & Berry, M. J. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700330 · Cited by 544
Selenium, Selenoproteins and Viral Infection
Guillin, O., Vindry, C., Ohlmann, T., & Chavatte, L. (2019) · Nutrients · doi:10.3390/nu11092101 · Cited by 443
Garland, E. L., Manusov, E. G., Froeliger, B., Kelly, A., Williams, J. M., & Howard, M. O. (2014) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0035798 · Cited by 431
“…estimation conducted within the Analysis of Moment Structures 17.0 (AMOS 17.0) software package, a method that has been employed previously to assess clinical trial outcomes in biomedical (Hurwitz et al., 2007) and psychotherapy (Durham, Chambers, MacDonald, Power, & Major, 2003) studies.”
MethodInfluentialThe Role of Selenium in Pathologies: An Updated Review
Barchielli, G., Capperucci, A., & Tanini, D. (2022) · Antioxidants · doi:10.3390/antiox11020251 · Cited by 371
Proposed Recommended Nutrient Densities for Moderately Malnourished Children
Golden, M. H. (2009) · Food and Nutrition Bulletin · doi:10.1177/15648265090303s302 · Cited by 302
Dietary Selenium in Adjuvant Therapy of Viral and Bacterial Infections
Steinbrenner, H., Al-Quraishy, S., Dkhil, M. A., Wunderlich, F., & Sies, H. (2015) · Advances in Nutrition · doi:10.3945/an.114.007575 · Cited by 298
Schomburg, L., & Köhrle, J. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700465 · Cited by 278
Role of divalent metals in infectious disease susceptibility and outcome
Weiss, G., & Carver, P. L. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.01.018 · Cited by 123
EURRECA—Estimating Selenium Requirements for Deriving Dietary Reference Values
Hurst, R., Collings, R., Harvey, L. J., King, M., Hooper, L., Bouwman, J., Gurinovic, M., & Fairweather-Tait, S. J. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2012.742861 · Cited by 110
Garland, E. L., Baker, A. K., & Howard, M. O. (2017) · Journal of the Society for Social Work and Research · doi:10.1086/694324 · Cited by 47
Metadata
- Authors
- Hurwitz, B. E.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2007-01-22
- Volume
- 167
- Issue
- 2
- Pages
- 148
- ISSN
- 0003-9926
- OpenAlex
- W2142395069
- Cited by
- 231
- References
- 2
- FWCI
- 15.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.